Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

IsoSpec Analytics SA

History from 7 Oct 2022

UID
CHE-201.826.759
Legal form
AG
Canton
VD
Founded
7 Oct 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 165k
41k82k124k165k12 Feb 2024 · CHF 132k12 Mar 2026 · CHF 165kRound announced 26 Jun 2026202420252026
  • shares
  • privilégiées "Pre Seed", privilégiées quant au produit de liquidation
  • privilégiées "Seed", privilégiées quant au produit de liquidation
  • round announced

Record

  1. Company formed

    Founded 7 Oct 2022

    SHAB HR01-1005590690 ↗
  2. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    100’000 → 132’170
    Shares
    — → 1’321’700
    New shares, % of post-step shares
    — (share counts not published)
    Share classes
    1’000’000 × CHF 0.10 · 321’700 × CHF 0.10 privilégiées "Pre Seed", privilégiées quant au produit de liquidation

    Le capital-actions de CHF 100'000 a été libéré ultérieurement à concurrence de CHF 50'000. Nouveau capital-actions entièrement libéré: CHF 132'170, divisé en 1'000'000 actions nominatives de CHF 0.10, et 321'700 actions nominatives privilégiées "Pre Seed" de CHF 0.10, privilégiées quant au produit de liquidation, toutes avec restrictions quant à la transmissibilité selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005959000 ↗
  3. Capital increase

    Confirmed round

    Paid in cash and by other means

    Nominal capital
    132’170 → 164’985.20
    Shares
    1’321’700 → 1’649’852
    New shares, % of post-step shares
    19.9% (328’152 new)
    Share classes
    1’000’000 × CHF 0.10 · 321’700 × CHF 0.10 privilégiées "Pre Seed", privilégiées quant au produit de liquidation · 328’152 × CHF 0.10 privilégiées "Seed", privilégiées quant au produit de liquidation

    Nouveau capital-actions entièrement libéré: CHF 164'985.20, divisé en 1'000'000 actions nominatives de CHF 0.10, 321'700 actions nominatives privilégiées "Pre Seed" de CHF 0.10, privilégiées quant au produit de liquidation, et 328'152 actions nominatives privilégiées "Seed" de CHF 0.10, privilégiées quant au produit de liquidation, toutes avec restrictions quant à la transmissibilité selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.93 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006594749 ↗
  4. Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

Published by 8 Oct 2026